Stay updated on AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial

Sign up to get notified when there's something new on the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The record now presents details for the completed Phase 2 study of AK002 for antihistamine-resistant chronic urticaria, including eligibility criteria, study design, outcome measures, locations, and results-reporting dates.
    Difference
    46%
    Check dated 2026-11-08T01:12:34.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T19:22:29.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T22:11:56.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer site revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T22:00:33.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.0 to v3.7.1 while the study page remains unavailable behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:05:34.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The detailed study record content was deleted and replaced with a 403 Forbidden page, leaving only a basic header and navigation; the page now shows a restricted access state.
    Difference
    17%
    Check dated 2026-09-19T21:47:29.000Z thumbnail image

Stay in the know with updates to AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page.